Cargando…
Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other variants of concern and impact on diagnostic testing strategy
Autores principales: | Matic, Nancy, Lowe, Christopher F., Ritchie, Gordon, Young, Matthew, Lawson, Tanya, Romney, Marc G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093080/ https://www.ncbi.nlm.nih.gov/pubmed/35568306 http://dx.doi.org/10.1016/j.cmi.2022.04.022 |
Ejemplares similares
-
Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021) -
SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape
por: Sanyaolu, Adekunle, et al.
Publicado: (2022) -
The rapid replacement of the Delta variant by Omicron (B.1.1.529) in England
por: Paton, Robert S., et al.
Publicado: (2022) -
Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
por: Grüne, Barbara, et al.
Publicado: (2022) -
Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
por: Chun, June Young, et al.
Publicado: (2022)